hvs 2020€¦ · hvs is truly multi-disciplinary, with leaders in cardiac surgery, cardiology,...

Live cases and hands on training from Cleveland Clinic Abu Dhabi.

Join the Heart Team in Action!

HVS 2020ROSE WOOD, ABU DHABI

February 15 - 16, 2020February 14 - ICTEHV Meeting

Cardiologists | Scientists | Surgeons | Structural Heart Team | Patients


Dear Colleagues and Friends,

I am humbled to serve the Heart Valve Society (HVS) as President this year, and am delighted to invite you to Abu Dhabi to join us in February of 2020 for our sixth Annual Meeting. Our Program Chair Dr. Samir Kapadia, as well as our organizing teams in cooperation with the Program Committee, have structured a superb 2-days program which will engage and educate all members of the heart valve team. This is our first meeting held globally outside of Europe or North America. We will be co-hosting several local societies, as we continue to expand membership in the only society solely dedicated to advancing innovations in heart valve disease. The HVS is a global organization, and our mission is to be a resource for scientists, clinicians and patients interested in heart valve disease throughout the world.HVS is truly multi-disciplinary, with leaders in Cardiac Surgery, Cardiology, Basic and Clinical Research, Imaging, and Biomedical engineering all working together. As the treatment of heart valve disease becomes more team-oriented each year, and it is fitting that our 2020 program will be hosted at the beautiful Rosewood Hotel with live cases and hands-on-sessions at the adjoining Cleveland Clinic Abu Dhabi campus – a 40,000 square foot state of the art tertiary/quaternary Academic Medical Center. Our 2020 scientific domains will be led by Dr. Kapadia in Cardiology, Dr. Vinod Thourani in Cardiac surgery, Dr. Hanneke (Johanna) Takkenberg in Research/Basic Science, and Dr. Marta Sitges in Imaging. Each is a world-respected leader in their field, bringing vast expertise to the program, allowing them to attract an impressive faculty with an international perspective.In addition to the historic educational opportunity for you our attendees, the 2020 Annual Meeting will also give the heart valve team members the chance to experience the beauty and richness of Abu Dhabi - the warm sunshine, the sugar sand beaches, the crystal clear waters, the iconic Louvre and the cultural hospitality of the United Arab Emirates. I urge you to arrive a day or two early, bring your family or a guest, and enjoy Valentine’s Day February 14th with us.Once again, on behalf of the Heart Valve Society leadership team, we look forward to warmly welcoming you to HVS 2020 in sunny, safe and memorable Abu Dhabi.

Sincerely,Rakesh Suri, MD, D.Phil.Heart Valve Society President


FRIDAY, FEBRUARY 14, 202009.00 am 05.00 pm International Conference of Tissue Engineered Heart Valves (ICTEHV)

SATURDAY, FEBRUARY 15, 2020ROOM 1 ROOM 2 ROOM 3 ROOM 4

08.50 am Welcome and Opening of the 6th Annual Meeting

09.00 am Plenary Session I: Masters Perspective in Valve Therapy (Surgical and

percutaneous leaders to talk about each valve)11.00 am Coffee Break

11.30 am Live Case: TAVR (VIV, Bicuspid)

Baisc Science: Image-Based Computational Valve Models

for Patient-Centered Approaches

Imaging:Mitral

Abstracts:Pul Valve

01.00 pm Industry Lunch + VRN Meetings

02.00 pm Plenary Session II: Aortic Valve (Low risk, Surgical AVR role, Cerebral

protection, Bicuspid, VIV PPM, Basilica, AR)04.00 pm Coffee Break

04.30 pm Live Case: Mitral (Clip, Cardioband, Pascal, MVIV)

Basic Science:Understanding Bioprosthetic Valve

Degeneration to Advance TAVR

Imaging: Aortic

Abstracts:TV

06.00 pm07.30 pm

Poster Competition and Reception

SUNDAY, FEBRUARY 16, 2020ROOM 1 ROOM 2 ROOM 3 ROOM 4

09.00 am Plenary Session III: Mitral Valve (DMR surgery, FMR surgery, Clip, Annular

repair, Choradal repair, TMVR, VIV/VIR/VIMAC)11.00 am Coffee Break

11.30 am Live Case: Mini AV, Sutureless valve, AV repair

Basic Science:Emerging Technologies, Hot Topics, Techno-

logical Advances and Drug Discovery

Imaging: TV/PHTN

Abstracts:Mitral

01.00 pm Industry Lunch + VRN Meetings

02.00 pm Plenary Session IV: (Tricuspid repair, ACHD, Pulmonary valve, surgical

and percut valve complications)04.00 pm Coffee Break

04.30 pm Live Case: Robotic MVR, MAC, Mini MVRepair, Artificial Chordae

Basic Science:Extracellular Vescicles, Biomarkers, Amyloidosis, Thrombosis, Fibrosis

Imaging:Multivalve

Abstracts:Aortic

06.00 pm07.30 pm

SYNOPSIS

PRELIMINARY PROGRAM

4

FRIDAY, 14 FEBRUARY 2020

ICTEHV Conference

10:00 am – 1:00 pm ICHOM Meeting

3:00 pm – 5:00 pm HVS Board of Directors Meeting

HEART VALVE SOCIETY 20206th ANNUAL SCIENTIFIC MEETING I FEBRUARY 15-16, 2020

5

SATURDAY, 15 FEBRUARY 2020

9:00 am – 11:00 am Plenary Session I: Masters of Valvular Heart Disease

Moderators: Rakesh Suri (United Arab Emirates), Johanna Takkenberg (Netherlands)

Discussants: Jose Pomar (Spain), Jeffrey Borer (United States), Zuhair Al-Halees (Saudi Arabia)

9:00 am – 9:15 am How I witnessed the evolution of Surgical Aortic Valve Replacement

9:15 am – 9:30 am How I witnessed the evolution of Transcatheter Aortic Valve Treatment

9:30 am – 9:40 am Case Presentation of Aortic Stenosis –SAVR vs TAVR Konstantinos Spargias (Greece)

9:40 am – 9:45 am Discussion

9:45 am – 10:00 am How I witnessed the evolution of Surgical Mitral Valve Treatment Gilles Dreyfus (Monaco)

10:00 am – 10:15 am How I witnessed the evolution of Transcatheter Mitral Valve TreatmentFrancesco Maisano (Switzerland)

10:15 am – 10:30 am How I witnessed the Evolution in Imaging of the ValvesCase Based Examples


10:35 am – 11:00 am Precedential Address

Rakesh Suri

11:00 am – 11:30 am Coffee Break

11:30 am – 1:00 pm Live Case - TAVR (VIV, Bicuspid)

Discussants: Ziyad Ghazzal (Lebanon), Michael Lee (Hong Kong), Greg Pattakos (Greece), Adil Al Kindi (Greece), Fadi Sawaya (Lebanon)

PRELIMINARY PROGRAM

6


11:30 am – 1:00 pm Basic Science – Image-Based Computational Valve Models for Patient-Centered Approaches

Moderators: Manuel Rausch (United States), Elaine Tseng (United States),

Discussants: Morten Jensen (United States), Alison Pouch (United States), Michael Sacks (United States), Manuel Rausch (United States)

11:30 am – 11:42 am Preclinical Computational Valve Models Morten Jensen (United States)


11:45 am – 11:57 am Echo-Based Computational Valve ModelsAlison Pouch (United States)

11:57 am – 12:00 pm Discussion

12:00 pm – 12:12 pm CT-Based Computational Valve ModelsWei Sun

12:12 pm – 12:15 pm Discussion

12:15 pm – 12:27 pm Computational Valve Models for Surgical PlanningMichael Sacks (United States)


12:30 pm – 12:42 pm Experimental Validation of Computational Valve ModelsManuel Rausch (United States)

12:42 am – 1.00 pm Discussion


7


11:30 am – 1:00 pm Imaging and Clinical Decision Making Session – Mitral

Moderators: Jean Louis Vanoverschelde (Belgium) and Patrick Perrier (France)

Discussants: Mohammed Khalil (United Arab Emirates)

11:30 am – 11:40 am Echo assessment of DMR – How does it help clinical decision makingMaurice Sarano (United States)

11:40 am – 11:50 am Atrial and ventricular FMR – Identification and ManagementDee Dee Wang (United States)


12:00 am – 12:10 pm Radiation Induced Mitral Valve Disease – How to Select Best Treatment OptionsMilind Desai (United States)

12:10 pm – 12:20 pm Assessment of LV function in Patients with severe MR – Is Clinical Improvement likely with Reduction in MR?Marta Sitges (Spain)


12:30 pm – 12:40 pm Imaging Considerations for Mitral Edge to Edge Repair Nina Wunderlich (Germany)

12:40 pm – 12:50 pm Anatomy of Mitral Valve in Surgery – What does imaging help?Patrick Perier (France)


11:30 am – 1:00 pm Abstracts – Pulmonary Valve

1:00 pm – 1:50 pm Lunch

1:50 pm – 2:50 pm Industry Session

PRELIMINARY PROGRAM

8


2:50 pm – 4:50 pm Plenary Session II: Aortic Valve (Low risk, Surgical AVR role, Cerebral protection, Bicuspid, VIV PPM, Basilica, AR)

Moderators: Catherine Otto (United States), Ismail El-Hanamsy (Canada)

Discussants: Mohammed Balghith (Saudi Arabia), Ahmad Edris (United Arab Emirates)

2:50 pm – 3:00 pm TAVR among lower risk groupsSamir Kapadia (United States)

3:00 pm – 3:10 pm Surgical AVR in the era of TAVR – mini techniques, OzakiVinod Thourani (United States)


3:18 pm – 3:26 pm Bicuspid AS – Best treated with SAVRJolanda Kluin (Netherlands)

3:26 pm – 3:34 pm Bicuspid – Best Treated with TAVRMurat Tuzcu (United States)


3:42 pm – 3:50 pm Cerebral embolic protection for TAVRAmar Krishnaswamy (United States Minor Outlying Islands)

3:50 pm – 3:58 pm Coronary protection techniques in TAVRMegan Coylewright (United States)

3:58 pm – 4:06 pm Bioprosthetic valve fracture for valve-in-valve TAVRDanny Dvir (United States)


4:14 pm – 4:24 pm TAVR for pure AR Rodes Cabau (Canada)

4:24 pm – 4:34 pm Surgical AV repair for pure ARLaurent De Kerchove (Belgium)


4:40 pm – 4:50 pm Newer TAVR technologies (ACCURATE, JENA, LOTUS EDGE, etc.)Alexandre Abizaid (Brazil)

4:50 pm – 5:20 pm Coffee Break

5:20 pm – 6:50 pm Live Case: Mitral (Clip, Cardioband, Pascal, MVIV)

Discussants: Ibrahim Rashdan (Kuwait), Mohammed Al Mukhaini (Oman)


9


5:20 pm – 6:50 pm Basic Science – Understanding Bioprosthetic Valve Degeneration to Advance TAVR

Moderators: Mostafa Mokhles (Netherlands), Hanneke Takkenberg (Netherlands)

Discussants: Frederick Schoen (United States), Gino Gerosa (Italy), Carlijn Bouten (Netherlands), Nicholas van Mieghem (Netherlands)

5:20 pm – 5:32 pm The mechanism of bioprosthetic valve calcification Frederick Schoen (United States)


5:35 pm – 5:47 pm Prevention of calcification in bioprosthetic heart valves: challenges and perspectives Philippe Pibarot


5:50 pm – 6:02 pm Imaging techniques in the detection of early bioprosthetic valve degeneration Gino Gerosa (Italy)


6:05 pm – 6:25 pm DEBATE: Will tissue engineered valves be the future of TAVR? Pro: Carlijn Bouten (Netherlands)Con: Nicolas van Mieghem (Netherlands)


6:35 pm – 6:50 pm Discussion: What will be the challenges in evolution of TAVR?

PRELIMINARY PROGRAM

10


5:20 pm – 6:50 pm Imaging and Clinical Decision Making – Aortic

Moderators: Arturo Evangelista, Marjan Jahanhiri (United Kingdom)

Discussants: Ahmed Bafadel (United Arab Emirates), Said Al Hinai (Oman)

5:20 pm – 5:30 pm Hemodynamic Assessment of AS in Cath lab and by EchocardiographyJoseph Maalouf (United States)

5:30 pm – 5:40 pm Multidisciplinary approach to assessing the patient with AS and low flow low gradientVictoria Delgado


5:50 pm – 6:00 pm CT imaging of AS – Procedural PlanningJonathon Leipsic (Canada)

6:10 pm – 6:20 pm Assessment of Aorta in patients with aortic valve diseaseMilind Desai (United States)


6:30 pm – 6:40 pm What is low risk TAVR anatomy (and what is not?)Amar Krishnaswamy (United States Minor Outlying Islands)


5:20 pm – 6:50 pm Abstracts – TV

6:50 pm – 8:20 pm Poster Competition and Welcome Reception


11

SUNDAY, 16 FEBRUARY 2020

8.15 am – 8.45 am Quality assessment in 21st century

Eugene Blackstone (United States)

8.45 am – 9.00 am HVS Members Business Meeting

9:00 am – 11:00 am Plenary Session III: Mitral Valve (DMR surgery, FMR surgery, Clip, Annular repair, Chordal repair, TMVR, VIV/VIR/VIMAC)

Moderators: Jose Pomar (Spain)

Discussants: Victor Jebara (Lebanon), Gurjyot Bajwa (United Arab Emirates), Kenny Sin (Singapore)

9:00 am – 9:10 am MR Pathology and ClassificationAlain Berrebi (France)

9:10 am – 9:20 am Timing of DMR surgery: should we wait for symptoms?Jean Louis Vanoverschelde (Belgium)

9:20 am – 9:30 am Outcomes of MitraClip for Degenerative MRNina Wunderlich (Germany)


9:35 am – 9:45 am Robotic MV surgery: technique and resultsRakesh Suri (United Arab Emirates)

9:45 am – 9:55 am Surgical MV repair vs replacement for functional MRMarc Gillinov (United States)

9:55 am – 10:05 am Outcomes of MitraClip for Functional MRJean François Obadia (France)


10:10 am – 10:20 am Percutaneous Annuloplasty Techniques for FMRSamir Kapadia (United States)

10:20 am – 10:30 am Percutaneous chordal repair strategies for MRAndrea Colli (Italy)


10:35 am – 10:45 am Transcatheter mitral valve replacement devicesMartin Leon (United States)

10:45 am – 10:55 am Mitral Valve in Valve, Valve in Ring, Valve in MACMayra Guerrero (United States)


11:00 am – 11:30 am Coffee Break

PRELIMINARY PROGRAM

12


11:30 am – 1:00 pm Live Case - Mini AV, Sutureless valve, AV repair

Discussants: Gopal Bhatnagar (United Arab Emirates), Iyad Tarazi, Tarek Alameddine

11:30 am – 1:00 pm Basic Science – Emerging Technologies, Hot Topics, Technological Advances and Drug Discovery

Moderators: Elena Aikawa (United States), Carlijn Bouten (Netherlands)

Discussants: Sam Tsimikas (United States), Bernard Vennemann (Switzerland), Anna Helgadottir (Iceland), Rajat Gupta (United States), Joseph Wu (United States)

11:30 am – 11:42 am Biomarker discovery in aortic valve stenosisSotirios (Sam) Tsimikas (United States)


11:45 am – 11:57 am Machine learning to detect heart valve degenerationBernard Vennemann (Switzerland)


12:00 am – 12:12 am Single cell analysis of endothelial cell population: Implications for heart valve diseaseRajat Gupta (United States)

12:12 am - 12:15 am Discussion

12:15 am – 12:27 am Genome-wide analysis of heart valve disease Anna Helgadottir (Iceland)


12:30 am – 12:42 am Multi-Omics in cardiovascular disease mapping and drug discovery Elena Aikawa (United States)


12:45 am – 12:57 am Genome editing in cardiovascular medicine Joseph C. Wu (United States)

12:57 am – 1:00 pm Discussion


13


11:30 am – 1:00 pm Imaging and Clinical Decision Making – AR/TV/PHTN

Moderators: Judy Hung (United States)

Discussants: Victor Chao (Singapore), Nasser Al Kemyani (Oman)

11:30 am – 11:40 am Should we lower the threshold for intervention in aortic regurgitation? Jean Louis Vanoverschelde (Belgium)


11:45 am – 11:55 am Selection of patients suitable for aortic valve repairAlain Berrebi (France)


12:00 am – 12:10 am Outcomes of aortic valve repair in 2020Irem Karliova (Germany)


12:15 am – 12:25 am TV imaging for Edge to Edge RepairDee Dee Wang (United States)


12:30 am – 12:40 am Assessment of TR and Right Ventricular FunctionJoseph Maalouf (United States)

12:40 am– 12:45 am Discussion

12:45 am – 12:55 am Pulmonary HTN – Implications in management of TRSusan Price (United Kingdom)


11:30 am – 1:00 pm Abstracts – Mitral

Moderators: Denisa Muraru

Discussants: Greg Pattakos (Greece)

1:00pm – 1:50 pm Lunch

1:50pm – 2:50pm Industry Session

PRELIMINARY PROGRAM

14


2:50 pm – 4:50 pm Plenary Session IV: Tricuspid Valve (Tricuspid repair, ACHD, Pulmonary valve, surgical and percut valve complications)

Moderators: Maurice Sarano (United States), Gilles Dreyfus (Monaco)

Discussants: Nina Wunderlich (Germany), Arturo Evangelista, Zuhair Al-Halees (Saudi Arabia)

2:50 pm – 3:00 pm Tricuspid valve anatomy and pathologyDenisa Muraru


3:05 pm – 3:15 pm Surgical Indications for TR: when, why, and outcomesYan Topilsky (Israel)


3:20 pm – 3:30 pm Use of the Edge to Edge repair for treating TR: anatomic feasibility and outcomesRalph Stephan Von Bardeleben (Germany)


3:40 pm – 3:50 pm Percutaneous Tricuspid annuloplastyJosep Rodes (Canada)


4:00 pm – 4:10 pm Imaging for TVRhoda Miyasaka (United States)


4:20 pm – 4:30 pm Transcatheter Valve Treatment for Adult Congenital Heart Disease patientsNidal Abi Rafeh (Lebanon)

4:30 pm - 4:40 pm Management of Pulmonary Valve in ACHD patients Moaid Alzaibag


4:50 pm – 5:20 pm Coffee Break

5:20 pm – 6:50 pm Live Case: Mitral Robotic MVR, MAC, Mini MVRepair, Artificial Chordae

Discussants: Gurjyot Bajwa (United Arab Emirates), Tarek Alameddine, Sorin Pislaru (United States), Abdallah El Sabbagh (United States)


15


5:20 am – 6:50 pm Basic Science – Extracellular Vescicles, Biomarkers, Amyloidosis, Thrombosis, Fibrosis

Moderators: Carlijn Bouten (Netherlands), Elena Aikawa (United States)

Discussants: Joshua Hutcheson (United States), Leon Schurgers (Netherlands), Robert Levine (United States), Wendy Liu (United States), James Moon (United Kingdom), Kristy Anseth (United States)

5:20pm – 5:32 pm Controversies in cardiovascular calcification: valvular vs vascular Joshua Hutcheson (United States)


5:35 pm – 5:47 pm Extracellular vesicles and their roles in cardiovascular diseases and calcificationLeon Schurgers (Netherlands)


5:50 pm – 6:02 pm Valvular fibrosis: Can we win the race? Robert Levine (United States)


6:05 pm – 6:17 pm Emerging players in valve disease: Adaptive vs innate immunity Wendy Liu (United States)


6:20 pm – 6:32 pm Understanding amyloidosis in TAVR patientsJames Moon (United Kingdom)


6:35 pm – 6:47 pm Circulating serum factors to mediate myofibroblast deactivation following TAVI Kristy Anseth (United States)


PRELIMINARY PROGRAM

16


5:20 am – 6:50 pm Imaging and Clinical Decision Making – Multivalve

Discussants: Josep Rodes (Canada), Khalid Buresly (Kuwait), Alex Lee (Hong Kong)

5:20 pm – 5:30 pm Assessment of MR in patients with AS Hector Michelena (United States)


5:35 pm – 5:45 pm Echocardiographic evaluation of mixed aortic valve disease Arturo Evangelista


5:50 pm – 6:00 pm Prosthetic valve assessment – stenosis and valvular or paravalvular regurgitationAlain Berrebi


6:05 pm – 6:15 pm Mitral Stenosis – Assessment and Percutaneous TreatmentLeonardo Rodriguez (United States)


6:20 pm – 6:30 pm Added value of cardiac MRI in assessing valve disease?Caroline Van de Heyning (Belgium)


6:35 pm – 6:45 pm When is invasive hemodynamic assessment necessary?Murat Tuzcu (United States)


5:20 pm – 6:50 pm Abstracts – Pulmonary Aortic

Moderators: Jolanda Kluin (Netherlands), Liesl Zuhlke (South Africa)

6:50 pm – 7:05 pm HVS Members Business Meeting– MOVE

hvs 2020€¦ · hvs is truly multi-disciplinary, with leaders in cardiac surgery, cardiology,...

Documents